Global Attenuated Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
According to our (Global Info Research) latest study, the global Attenuated Vaccine market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Attenuated Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Attenuated Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2017-2028
Global Attenuated Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2017-2028
Global Attenuated Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2017-2028
Global Attenuated Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Attenuated Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Attenuated Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., GlaxoSmithKline plc, Pfizer Inc, Sanofi and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Attenuated Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Attenuated Vaccine, with price, sales, revenue and global market share of Attenuated Vaccine from 2017 to 2022.
Chapter 3, the Attenuated Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Attenuated Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Attenuated Vaccine.
Chapter 14 and 15, to describe Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Attenuated Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Attenuated Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2017-2028
Global Attenuated Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2017-2028
Global Attenuated Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2017-2028
Global Attenuated Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Attenuated Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Attenuated Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., GlaxoSmithKline plc, Pfizer Inc, Sanofi and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Attenuated Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Bacterial Vaccine
- Viral Vaccine
- Hospital
- Clinic
- Others
- Merck & Co.
- GlaxoSmithKline plc
- Pfizer Inc
- Sanofi
- Astellas Pharma
- Johnson & Johnson
- CSL Limited
- Serum Institute of India Pvt. Ltd.
- Biken
- Green Cross Corporation
- Shanghai Rongsheng Biotech
- Changchun BCHT Biotechnology Co.,Ltd
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Attenuated Vaccine, with price, sales, revenue and global market share of Attenuated Vaccine from 2017 to 2022.
Chapter 3, the Attenuated Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Attenuated Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Attenuated Vaccine.
Chapter 14 and 15, to describe Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Attenuated Vaccine Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Attenuated Vaccine Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 Bacterial Vaccine
1.3.3 Viral Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Attenuated Vaccine Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Attenuated Vaccine Market Size & Forecast
1.5.1 Global Attenuated Vaccine Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Attenuated Vaccine Sales Quantity (2017-2028)
1.5.3 Global Attenuated Vaccine Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Attenuated Vaccine Product and Services
2.1.4 Merck & Co. Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Merck & Co. Recent Developments/Updates
2.2 GlaxoSmithKline plc
2.2.1 GlaxoSmithKline plc Details
2.2.2 GlaxoSmithKline plc Major Business
2.2.3 GlaxoSmithKline plc Attenuated Vaccine Product and Services
2.2.4 GlaxoSmithKline plc Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 GlaxoSmithKline plc Recent Developments/Updates
2.3 Pfizer Inc
2.3.1 Pfizer Inc Details
2.3.2 Pfizer Inc Major Business
2.3.3 Pfizer Inc Attenuated Vaccine Product and Services
2.3.4 Pfizer Inc Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Pfizer Inc Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Attenuated Vaccine Product and Services
2.4.4 Sanofi Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Sanofi Recent Developments/Updates
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business
2.5.3 Astellas Pharma Attenuated Vaccine Product and Services
2.5.4 Astellas Pharma Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Astellas Pharma Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Attenuated Vaccine Product and Services
2.6.4 Johnson & Johnson Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 CSL Limited
2.7.1 CSL Limited Details
2.7.2 CSL Limited Major Business
2.7.3 CSL Limited Attenuated Vaccine Product and Services
2.7.4 CSL Limited Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 CSL Limited Recent Developments/Updates
2.8 Serum Institute of India Pvt. Ltd.
2.8.1 Serum Institute of India Pvt. Ltd. Details
2.8.2 Serum Institute of India Pvt. Ltd. Major Business
2.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
2.8.4 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
2.9 Biken
2.9.1 Biken Details
2.9.2 Biken Major Business
2.9.3 Biken Attenuated Vaccine Product and Services
2.9.4 Biken Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Biken Recent Developments/Updates
2.10 Green Cross Corporation
2.10.1 Green Cross Corporation Details
2.10.2 Green Cross Corporation Major Business
2.10.3 Green Cross Corporation Attenuated Vaccine Product and Services
2.10.4 Green Cross Corporation Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Green Cross Corporation Recent Developments/Updates
2.11 Shanghai Rongsheng Biotech
2.11.1 Shanghai Rongsheng Biotech Details
2.11.2 Shanghai Rongsheng Biotech Major Business
2.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
2.11.4 Shanghai Rongsheng Biotech Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Shanghai Rongsheng Biotech Recent Developments/Updates
2.12 Changchun BCHT Biotechnology Co.,Ltd
2.12.1 Changchun BCHT Biotechnology Co.,Ltd Details
2.12.2 Changchun BCHT Biotechnology Co.,Ltd Major Business
2.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
2.12.4 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Changchun BCHT Biotechnology Co.,Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ATTENUATED VACCINE BY MANUFACTURER
3.1 Global Attenuated Vaccine Sales Quantity by Manufacturer (2017-2022)
3.2 Global Attenuated Vaccine Revenue by Manufacturer (2017-2022)
3.3 Global Attenuated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Attenuated Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Attenuated Vaccine Manufacturer Market Share in 2021
3.5 Attenuated Vaccine Market: Overall Company Footprint Analysis
3.5.1 Attenuated Vaccine Market: Region Footprint
3.5.2 Attenuated Vaccine Market: Company Product Type Footprint
3.5.3 Attenuated Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Attenuated Vaccine Market Size by Region
4.1.1 Global Attenuated Vaccine Sales Quantity by Region (2017-2028)
4.1.2 Global Attenuated Vaccine Consumption Value by Region (2017-2028)
4.1.3 Global Attenuated Vaccine Average Price by Region (2017-2028)
4.2 North America Attenuated Vaccine Consumption Value (2017-2028)
4.3 Europe Attenuated Vaccine Consumption Value (2017-2028)
4.4 Asia-Pacific Attenuated Vaccine Consumption Value (2017-2028)
4.5 South America Attenuated Vaccine Consumption Value (2017-2028)
4.6 Middle East and Africa Attenuated Vaccine Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Attenuated Vaccine Sales Quantity by Type (2017-2028)
5.2 Global Attenuated Vaccine Consumption Value by Type (2017-2028)
5.3 Global Attenuated Vaccine Average Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Attenuated Vaccine Sales Quantity by Application (2017-2028)
6.2 Global Attenuated Vaccine Consumption Value by Application (2017-2028)
6.3 Global Attenuated Vaccine Average Price by Application (2017-2028)
7 NORTH AMERICA
7.1 North America Attenuated Vaccine Sales Quantity by Type (2017-2028)
7.2 North America Attenuated Vaccine Sales Quantity by Application (2017-2028)
7.3 North America Attenuated Vaccine Market Size by Country
7.3.1 North America Attenuated Vaccine Sales Quantity by Country (2017-2028)
7.3.2 North America Attenuated Vaccine Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Attenuated Vaccine Sales Quantity by Type (2017-2028)
8.2 Europe Attenuated Vaccine Sales Quantity by Application (2017-2028)
8.3 Europe Attenuated Vaccine Market Size by Country
8.3.1 Europe Attenuated Vaccine Sales Quantity by Country (2017-2028)
8.3.2 Europe Attenuated Vaccine Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Attenuated Vaccine Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Attenuated Vaccine Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Attenuated Vaccine Market Size by Region
9.3.1 Asia-Pacific Attenuated Vaccine Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Attenuated Vaccine Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Attenuated Vaccine Sales Quantity by Type (2017-2028)
10.2 South America Attenuated Vaccine Sales Quantity by Application (2017-2028)
10.3 South America Attenuated Vaccine Market Size by Country
10.3.1 South America Attenuated Vaccine Sales Quantity by Country (2017-2028)
10.3.2 South America Attenuated Vaccine Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Attenuated Vaccine Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Attenuated Vaccine Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Attenuated Vaccine Market Size by Country
11.3.1 Middle East & Africa Attenuated Vaccine Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Attenuated Vaccine Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Attenuated Vaccine Market Drivers
12.2 Attenuated Vaccine Market Restraints
12.3 Attenuated Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Attenuated Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Attenuated Vaccine
13.3 Attenuated Vaccine Production Process
13.4 Attenuated Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Attenuated Vaccine Typical Distributors
14.3 Attenuated Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Attenuated Vaccine Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Attenuated Vaccine Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 Bacterial Vaccine
1.3.3 Viral Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Attenuated Vaccine Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Attenuated Vaccine Market Size & Forecast
1.5.1 Global Attenuated Vaccine Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Attenuated Vaccine Sales Quantity (2017-2028)
1.5.3 Global Attenuated Vaccine Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Attenuated Vaccine Product and Services
2.1.4 Merck & Co. Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Merck & Co. Recent Developments/Updates
2.2 GlaxoSmithKline plc
2.2.1 GlaxoSmithKline plc Details
2.2.2 GlaxoSmithKline plc Major Business
2.2.3 GlaxoSmithKline plc Attenuated Vaccine Product and Services
2.2.4 GlaxoSmithKline plc Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 GlaxoSmithKline plc Recent Developments/Updates
2.3 Pfizer Inc
2.3.1 Pfizer Inc Details
2.3.2 Pfizer Inc Major Business
2.3.3 Pfizer Inc Attenuated Vaccine Product and Services
2.3.4 Pfizer Inc Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Pfizer Inc Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Attenuated Vaccine Product and Services
2.4.4 Sanofi Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Sanofi Recent Developments/Updates
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business
2.5.3 Astellas Pharma Attenuated Vaccine Product and Services
2.5.4 Astellas Pharma Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Astellas Pharma Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Attenuated Vaccine Product and Services
2.6.4 Johnson & Johnson Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 CSL Limited
2.7.1 CSL Limited Details
2.7.2 CSL Limited Major Business
2.7.3 CSL Limited Attenuated Vaccine Product and Services
2.7.4 CSL Limited Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 CSL Limited Recent Developments/Updates
2.8 Serum Institute of India Pvt. Ltd.
2.8.1 Serum Institute of India Pvt. Ltd. Details
2.8.2 Serum Institute of India Pvt. Ltd. Major Business
2.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
2.8.4 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
2.9 Biken
2.9.1 Biken Details
2.9.2 Biken Major Business
2.9.3 Biken Attenuated Vaccine Product and Services
2.9.4 Biken Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Biken Recent Developments/Updates
2.10 Green Cross Corporation
2.10.1 Green Cross Corporation Details
2.10.2 Green Cross Corporation Major Business
2.10.3 Green Cross Corporation Attenuated Vaccine Product and Services
2.10.4 Green Cross Corporation Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Green Cross Corporation Recent Developments/Updates
2.11 Shanghai Rongsheng Biotech
2.11.1 Shanghai Rongsheng Biotech Details
2.11.2 Shanghai Rongsheng Biotech Major Business
2.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
2.11.4 Shanghai Rongsheng Biotech Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Shanghai Rongsheng Biotech Recent Developments/Updates
2.12 Changchun BCHT Biotechnology Co.,Ltd
2.12.1 Changchun BCHT Biotechnology Co.,Ltd Details
2.12.2 Changchun BCHT Biotechnology Co.,Ltd Major Business
2.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
2.12.4 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Changchun BCHT Biotechnology Co.,Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ATTENUATED VACCINE BY MANUFACTURER
3.1 Global Attenuated Vaccine Sales Quantity by Manufacturer (2017-2022)
3.2 Global Attenuated Vaccine Revenue by Manufacturer (2017-2022)
3.3 Global Attenuated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Attenuated Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Attenuated Vaccine Manufacturer Market Share in 2021
3.5 Attenuated Vaccine Market: Overall Company Footprint Analysis
3.5.1 Attenuated Vaccine Market: Region Footprint
3.5.2 Attenuated Vaccine Market: Company Product Type Footprint
3.5.3 Attenuated Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Attenuated Vaccine Market Size by Region
4.1.1 Global Attenuated Vaccine Sales Quantity by Region (2017-2028)
4.1.2 Global Attenuated Vaccine Consumption Value by Region (2017-2028)
4.1.3 Global Attenuated Vaccine Average Price by Region (2017-2028)
4.2 North America Attenuated Vaccine Consumption Value (2017-2028)
4.3 Europe Attenuated Vaccine Consumption Value (2017-2028)
4.4 Asia-Pacific Attenuated Vaccine Consumption Value (2017-2028)
4.5 South America Attenuated Vaccine Consumption Value (2017-2028)
4.6 Middle East and Africa Attenuated Vaccine Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Attenuated Vaccine Sales Quantity by Type (2017-2028)
5.2 Global Attenuated Vaccine Consumption Value by Type (2017-2028)
5.3 Global Attenuated Vaccine Average Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Attenuated Vaccine Sales Quantity by Application (2017-2028)
6.2 Global Attenuated Vaccine Consumption Value by Application (2017-2028)
6.3 Global Attenuated Vaccine Average Price by Application (2017-2028)
7 NORTH AMERICA
7.1 North America Attenuated Vaccine Sales Quantity by Type (2017-2028)
7.2 North America Attenuated Vaccine Sales Quantity by Application (2017-2028)
7.3 North America Attenuated Vaccine Market Size by Country
7.3.1 North America Attenuated Vaccine Sales Quantity by Country (2017-2028)
7.3.2 North America Attenuated Vaccine Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Attenuated Vaccine Sales Quantity by Type (2017-2028)
8.2 Europe Attenuated Vaccine Sales Quantity by Application (2017-2028)
8.3 Europe Attenuated Vaccine Market Size by Country
8.3.1 Europe Attenuated Vaccine Sales Quantity by Country (2017-2028)
8.3.2 Europe Attenuated Vaccine Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Attenuated Vaccine Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Attenuated Vaccine Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Attenuated Vaccine Market Size by Region
9.3.1 Asia-Pacific Attenuated Vaccine Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Attenuated Vaccine Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Attenuated Vaccine Sales Quantity by Type (2017-2028)
10.2 South America Attenuated Vaccine Sales Quantity by Application (2017-2028)
10.3 South America Attenuated Vaccine Market Size by Country
10.3.1 South America Attenuated Vaccine Sales Quantity by Country (2017-2028)
10.3.2 South America Attenuated Vaccine Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Attenuated Vaccine Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Attenuated Vaccine Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Attenuated Vaccine Market Size by Country
11.3.1 Middle East & Africa Attenuated Vaccine Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Attenuated Vaccine Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Attenuated Vaccine Market Drivers
12.2 Attenuated Vaccine Market Restraints
12.3 Attenuated Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Attenuated Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Attenuated Vaccine
13.3 Attenuated Vaccine Production Process
13.4 Attenuated Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Attenuated Vaccine Typical Distributors
14.3 Attenuated Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Attenuated Vaccine Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Attenuated Vaccine Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Attenuated Vaccine Product and Services
Table 6. Merck & Co. Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. Merck & Co. Recent Developments/Updates
Table 8. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline plc Major Business
Table 10. GlaxoSmithKline plc Attenuated Vaccine Product and Services
Table 11. GlaxoSmithKline plc Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. GlaxoSmithKline plc Recent Developments/Updates
Table 13. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc Major Business
Table 15. Pfizer Inc Attenuated Vaccine Product and Services
Table 16. Pfizer Inc Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Pfizer Inc Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Attenuated Vaccine Product and Services
Table 21. Sanofi Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Sanofi Recent Developments/Updates
Table 23. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Astellas Pharma Major Business
Table 25. Astellas Pharma Attenuated Vaccine Product and Services
Table 26. Astellas Pharma Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Astellas Pharma Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Attenuated Vaccine Product and Services
Table 31. Johnson & Johnson Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 34. CSL Limited Major Business
Table 35. CSL Limited Attenuated Vaccine Product and Services
Table 36. CSL Limited Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. CSL Limited Recent Developments/Updates
Table 38. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Serum Institute of India Pvt. Ltd. Major Business
Table 40. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
Table 41. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 42. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 43. Biken Basic Information, Manufacturing Base and Competitors
Table 44. Biken Major Business
Table 45. Biken Attenuated Vaccine Product and Services
Table 46. Biken Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 47. Biken Recent Developments/Updates
Table 48. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Green Cross Corporation Major Business
Table 50. Green Cross Corporation Attenuated Vaccine Product and Services
Table 51. Green Cross Corporation Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 52. Green Cross Corporation Recent Developments/Updates
Table 53. Shanghai Rongsheng Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Rongsheng Biotech Major Business
Table 55. Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
Table 56. Shanghai Rongsheng Biotech Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 57. Shanghai Rongsheng Biotech Recent Developments/Updates
Table 58. Changchun BCHT Biotechnology Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Changchun BCHT Biotechnology Co.,Ltd Major Business
Table 60. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
Table 61. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 62. Changchun BCHT Biotechnology Co.,Ltd Recent Developments/Updates
Table 63. Global Attenuated Vaccine Sales Quantity by Manufacturer (2017-2022) & (K Doses)
Table 64. Global Attenuated Vaccine Revenue by Manufacturer (2017-2022) & (USD Million)
Table 65. Global Attenuated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Dose)
Table 66. Market Position of Manufacturers in Attenuated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 67. Head Office and Attenuated Vaccine Production Site of Key Manufacturer
Table 68. Attenuated Vaccine Market: Company Product Type Footprint
Table 69. Attenuated Vaccine Market: Company Product Application Footprint
Table 70. Attenuated Vaccine New Market Entrants and Barriers to Market Entry
Table 71. Attenuated Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Attenuated Vaccine Sales Quantity by Region (2017-2022) & (K Doses)
Table 73. Global Attenuated Vaccine Sales Quantity by Region (2023-2028) & (K Doses)
Table 74. Global Attenuated Vaccine Consumption Value by Region (2017-2022) & (USD Million)
Table 75. Global Attenuated Vaccine Consumption Value by Region (2023-2028) & (USD Million)
Table 76. Global Attenuated Vaccine Average Price by Region (2017-2022) & (US$/Dose)
Table 77. Global Attenuated Vaccine Average Price by Region (2023-2028) & (US$/Dose)
Table 78. Global Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 79. Global Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 80. Global Attenuated Vaccine Consumption Value by Type (2017-2022) & (USD Million)
Table 81. Global Attenuated Vaccine Consumption Value by Type (2023-2028) & (USD Million)
Table 82. Global Attenuated Vaccine Average Price by Type (2017-2022) & (US$/Dose)
Table 83. Global Attenuated Vaccine Average Price by Type (2023-2028) & (US$/Dose)
Table 84. Global Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 85. Global Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 86. Global Attenuated Vaccine Consumption Value by Application (2017-2022) & (USD Million)
Table 87. Global Attenuated Vaccine Consumption Value by Application (2023-2028) & (USD Million)
Table 88. Global Attenuated Vaccine Average Price by Application (2017-2022) & (US$/Dose)
Table 89. Global Attenuated Vaccine Average Price by Application (2023-2028) & (US$/Dose)
Table 90. North America Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 91. North America Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 92. North America Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 93. North America Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 94. North America Attenuated Vaccine Sales Quantity by Country (2017-2022) & (K Doses)
Table 95. North America Attenuated Vaccine Sales Quantity by Country (2023-2028) & (K Doses)
Table 96. North America Attenuated Vaccine Consumption Value by Country (2017-2022) & (USD Million)
Table 97. North America Attenuated Vaccine Consumption Value by Country (2023-2028) & (USD Million)
Table 98. Europe Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 99. Europe Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 100. Europe Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 101. Europe Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 102. Europe Attenuated Vaccine Sales Quantity by Country (2017-2022) & (K Doses)
Table 103. Europe Attenuated Vaccine Sales Quantity by Country (2023-2028) & (K Doses)
Table 104. Europe Attenuated Vaccine Consumption Value by Country (2017-2022) & (USD Million)
Table 105. Europe Attenuated Vaccine Consumption Value by Country (2023-2028) & (USD Million)
Table 106. Asia-Pacific Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 107. Asia-Pacific Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 108. Asia-Pacific Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 109. Asia-Pacific Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 110. Asia-Pacific Attenuated Vaccine Sales Quantity by Region (2017-2022) & (K Doses)
Table 111. Asia-Pacific Attenuated Vaccine Sales Quantity by Region (2023-2028) & (K Doses)
Table 112. Asia-Pacific Attenuated Vaccine Consumption Value by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Attenuated Vaccine Consumption Value by Region (2023-2028) & (USD Million)
Table 114. South America Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 115. South America Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 116. South America Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 117. South America Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 118. South America Attenuated Vaccine Sales Quantity by Country (2017-2022) & (K Doses)
Table 119. South America Attenuated Vaccine Sales Quantity by Country (2023-2028) & (K Doses)
Table 120. South America Attenuated Vaccine Consumption Value by Country (2017-2022) & (USD Million)
Table 121. South America Attenuated Vaccine Consumption Value by Country (2023-2028) & (USD Million)
Table 122. Middle East & Africa Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 123. Middle East & Africa Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 124. Middle East & Africa Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 125. Middle East & Africa Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 126. Middle East & Africa Attenuated Vaccine Sales Quantity by Region (2017-2022) & (K Doses)
Table 127. Middle East & Africa Attenuated Vaccine Sales Quantity by Region (2023-2028) & (K Doses)
Table 128. Middle East & Africa Attenuated Vaccine Consumption Value by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Attenuated Vaccine Consumption Value by Region (2023-2028) & (USD Million)
Table 130. Attenuated Vaccine Raw Material
Table 131. Key Manufacturers of Attenuated Vaccine Raw Materials
Table 132. Attenuated Vaccine Typical Distributors
Table 133. Attenuated Vaccine Typical Customers
Table 1. Global Attenuated Vaccine Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Attenuated Vaccine Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Attenuated Vaccine Product and Services
Table 6. Merck & Co. Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. Merck & Co. Recent Developments/Updates
Table 8. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline plc Major Business
Table 10. GlaxoSmithKline plc Attenuated Vaccine Product and Services
Table 11. GlaxoSmithKline plc Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. GlaxoSmithKline plc Recent Developments/Updates
Table 13. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc Major Business
Table 15. Pfizer Inc Attenuated Vaccine Product and Services
Table 16. Pfizer Inc Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Pfizer Inc Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Attenuated Vaccine Product and Services
Table 21. Sanofi Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Sanofi Recent Developments/Updates
Table 23. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Astellas Pharma Major Business
Table 25. Astellas Pharma Attenuated Vaccine Product and Services
Table 26. Astellas Pharma Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Astellas Pharma Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Attenuated Vaccine Product and Services
Table 31. Johnson & Johnson Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 34. CSL Limited Major Business
Table 35. CSL Limited Attenuated Vaccine Product and Services
Table 36. CSL Limited Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. CSL Limited Recent Developments/Updates
Table 38. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Serum Institute of India Pvt. Ltd. Major Business
Table 40. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
Table 41. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 42. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 43. Biken Basic Information, Manufacturing Base and Competitors
Table 44. Biken Major Business
Table 45. Biken Attenuated Vaccine Product and Services
Table 46. Biken Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 47. Biken Recent Developments/Updates
Table 48. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Green Cross Corporation Major Business
Table 50. Green Cross Corporation Attenuated Vaccine Product and Services
Table 51. Green Cross Corporation Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 52. Green Cross Corporation Recent Developments/Updates
Table 53. Shanghai Rongsheng Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Rongsheng Biotech Major Business
Table 55. Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
Table 56. Shanghai Rongsheng Biotech Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 57. Shanghai Rongsheng Biotech Recent Developments/Updates
Table 58. Changchun BCHT Biotechnology Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Changchun BCHT Biotechnology Co.,Ltd Major Business
Table 60. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
Table 61. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 62. Changchun BCHT Biotechnology Co.,Ltd Recent Developments/Updates
Table 63. Global Attenuated Vaccine Sales Quantity by Manufacturer (2017-2022) & (K Doses)
Table 64. Global Attenuated Vaccine Revenue by Manufacturer (2017-2022) & (USD Million)
Table 65. Global Attenuated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Dose)
Table 66. Market Position of Manufacturers in Attenuated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 67. Head Office and Attenuated Vaccine Production Site of Key Manufacturer
Table 68. Attenuated Vaccine Market: Company Product Type Footprint
Table 69. Attenuated Vaccine Market: Company Product Application Footprint
Table 70. Attenuated Vaccine New Market Entrants and Barriers to Market Entry
Table 71. Attenuated Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Attenuated Vaccine Sales Quantity by Region (2017-2022) & (K Doses)
Table 73. Global Attenuated Vaccine Sales Quantity by Region (2023-2028) & (K Doses)
Table 74. Global Attenuated Vaccine Consumption Value by Region (2017-2022) & (USD Million)
Table 75. Global Attenuated Vaccine Consumption Value by Region (2023-2028) & (USD Million)
Table 76. Global Attenuated Vaccine Average Price by Region (2017-2022) & (US$/Dose)
Table 77. Global Attenuated Vaccine Average Price by Region (2023-2028) & (US$/Dose)
Table 78. Global Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 79. Global Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 80. Global Attenuated Vaccine Consumption Value by Type (2017-2022) & (USD Million)
Table 81. Global Attenuated Vaccine Consumption Value by Type (2023-2028) & (USD Million)
Table 82. Global Attenuated Vaccine Average Price by Type (2017-2022) & (US$/Dose)
Table 83. Global Attenuated Vaccine Average Price by Type (2023-2028) & (US$/Dose)
Table 84. Global Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 85. Global Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 86. Global Attenuated Vaccine Consumption Value by Application (2017-2022) & (USD Million)
Table 87. Global Attenuated Vaccine Consumption Value by Application (2023-2028) & (USD Million)
Table 88. Global Attenuated Vaccine Average Price by Application (2017-2022) & (US$/Dose)
Table 89. Global Attenuated Vaccine Average Price by Application (2023-2028) & (US$/Dose)
Table 90. North America Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 91. North America Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 92. North America Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 93. North America Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 94. North America Attenuated Vaccine Sales Quantity by Country (2017-2022) & (K Doses)
Table 95. North America Attenuated Vaccine Sales Quantity by Country (2023-2028) & (K Doses)
Table 96. North America Attenuated Vaccine Consumption Value by Country (2017-2022) & (USD Million)
Table 97. North America Attenuated Vaccine Consumption Value by Country (2023-2028) & (USD Million)
Table 98. Europe Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 99. Europe Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 100. Europe Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 101. Europe Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 102. Europe Attenuated Vaccine Sales Quantity by Country (2017-2022) & (K Doses)
Table 103. Europe Attenuated Vaccine Sales Quantity by Country (2023-2028) & (K Doses)
Table 104. Europe Attenuated Vaccine Consumption Value by Country (2017-2022) & (USD Million)
Table 105. Europe Attenuated Vaccine Consumption Value by Country (2023-2028) & (USD Million)
Table 106. Asia-Pacific Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 107. Asia-Pacific Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 108. Asia-Pacific Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 109. Asia-Pacific Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 110. Asia-Pacific Attenuated Vaccine Sales Quantity by Region (2017-2022) & (K Doses)
Table 111. Asia-Pacific Attenuated Vaccine Sales Quantity by Region (2023-2028) & (K Doses)
Table 112. Asia-Pacific Attenuated Vaccine Consumption Value by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Attenuated Vaccine Consumption Value by Region (2023-2028) & (USD Million)
Table 114. South America Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 115. South America Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 116. South America Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 117. South America Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 118. South America Attenuated Vaccine Sales Quantity by Country (2017-2022) & (K Doses)
Table 119. South America Attenuated Vaccine Sales Quantity by Country (2023-2028) & (K Doses)
Table 120. South America Attenuated Vaccine Consumption Value by Country (2017-2022) & (USD Million)
Table 121. South America Attenuated Vaccine Consumption Value by Country (2023-2028) & (USD Million)
Table 122. Middle East & Africa Attenuated Vaccine Sales Quantity by Type (2017-2022) & (K Doses)
Table 123. Middle East & Africa Attenuated Vaccine Sales Quantity by Type (2023-2028) & (K Doses)
Table 124. Middle East & Africa Attenuated Vaccine Sales Quantity by Application (2017-2022) & (K Doses)
Table 125. Middle East & Africa Attenuated Vaccine Sales Quantity by Application (2023-2028) & (K Doses)
Table 126. Middle East & Africa Attenuated Vaccine Sales Quantity by Region (2017-2022) & (K Doses)
Table 127. Middle East & Africa Attenuated Vaccine Sales Quantity by Region (2023-2028) & (K Doses)
Table 128. Middle East & Africa Attenuated Vaccine Consumption Value by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Attenuated Vaccine Consumption Value by Region (2023-2028) & (USD Million)
Table 130. Attenuated Vaccine Raw Material
Table 131. Key Manufacturers of Attenuated Vaccine Raw Materials
Table 132. Attenuated Vaccine Typical Distributors
Table 133. Attenuated Vaccine Typical Customers
LIST OF FIGURES
s
Figure 1. Attenuated Vaccine Picture
Figure 2. Global Attenuated Vaccine Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Attenuated Vaccine Consumption Value Market Share by Type in 2021
Figure 4. Bacterial Vaccine Examples
Figure 5. Viral Vaccine Examples
Figure 6. Global Attenuated Vaccine Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 7. Global Attenuated Vaccine Consumption Value Market Share by Application in 2021
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Others Examples
Figure 11. Global Attenuated Vaccine Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 12. Global Attenuated Vaccine Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 13. Global Attenuated Vaccine Sales Quantity (2017-2028) & (K Doses)
Figure 14. Global Attenuated Vaccine Average Price (2017-2028) & (US$/Dose)
Figure 15. Global Attenuated Vaccine Sales Quantity Market Share by Manufacturer in 2021
Figure 16. Global Attenuated Vaccine Consumption Value Market Share by Manufacturer in 2021
Figure 17. Producer Shipments of Attenuated Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2021
Figure 19. Top 6 Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Global Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 21. Global Attenuated Vaccine Consumption Value Market Share by Region (2017-2028)
Figure 22. North America Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 23. Europe Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 24. Asia-Pacific Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 25. South America Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 26. Middle East & Africa Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 27. Global Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 28. Global Attenuated Vaccine Consumption Value Market Share by Type (2017-2028)
Figure 29. Global Attenuated Vaccine Average Price by Type (2017-2028) & (US$/Dose)
Figure 30. Global Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 31. Global Attenuated Vaccine Consumption Value Market Share by Application (2017-2028)
Figure 32. Global Attenuated Vaccine Average Price by Application (2017-2028) & (US$/Dose)
Figure 33. North America Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 34. North America Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 35. North America Attenuated Vaccine Sales Quantity Market Share by Country (2017-2028)
Figure 36. North America Attenuated Vaccine Consumption Value Market Share by Country (2017-2028)
Figure 37. United States Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 38. Canada Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Mexico Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Europe Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 41. Europe Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 42. Europe Attenuated Vaccine Sales Quantity Market Share by Country (2017-2028)
Figure 43. Europe Attenuated Vaccine Consumption Value Market Share by Country (2017-2028)
Figure 44. Germany Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 45. France Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. United Kingdom Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. Russia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Italy Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Asia-Pacific Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 50. Asia-Pacific Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 51. Asia-Pacific Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Attenuated Vaccine Consumption Value Market Share by Region (2017-2028)
Figure 53. China Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 54. Japan Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Korea Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. India Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. Southeast Asia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Australia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. South America Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 60. South America Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 61. South America Attenuated Vaccine Sales Quantity Market Share by Country (2017-2028)
Figure 62. South America Attenuated Vaccine Consumption Value Market Share by Country (2017-2028)
Figure 63. Brazil Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East & Africa Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 66. Middle East & Africa Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 67. Middle East & Africa Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 68. Middle East & Africa Attenuated Vaccine Consumption Value Market Share by Region (2017-2028)
Figure 69. Turkey Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 70. Egypt Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Africa Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. Attenuated Vaccine Market Drivers
Figure 74. Attenuated Vaccine Market Restraints
Figure 75. Attenuated Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Attenuated Vaccine in 2021
Figure 78. Manufacturing Process Analysis of Attenuated Vaccine
Figure 79. Attenuated Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
s
Figure 1. Attenuated Vaccine Picture
Figure 2. Global Attenuated Vaccine Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Attenuated Vaccine Consumption Value Market Share by Type in 2021
Figure 4. Bacterial Vaccine Examples
Figure 5. Viral Vaccine Examples
Figure 6. Global Attenuated Vaccine Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 7. Global Attenuated Vaccine Consumption Value Market Share by Application in 2021
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Others Examples
Figure 11. Global Attenuated Vaccine Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 12. Global Attenuated Vaccine Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 13. Global Attenuated Vaccine Sales Quantity (2017-2028) & (K Doses)
Figure 14. Global Attenuated Vaccine Average Price (2017-2028) & (US$/Dose)
Figure 15. Global Attenuated Vaccine Sales Quantity Market Share by Manufacturer in 2021
Figure 16. Global Attenuated Vaccine Consumption Value Market Share by Manufacturer in 2021
Figure 17. Producer Shipments of Attenuated Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2021
Figure 19. Top 6 Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Global Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 21. Global Attenuated Vaccine Consumption Value Market Share by Region (2017-2028)
Figure 22. North America Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 23. Europe Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 24. Asia-Pacific Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 25. South America Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 26. Middle East & Africa Attenuated Vaccine Consumption Value (2017-2028) & (USD Million)
Figure 27. Global Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 28. Global Attenuated Vaccine Consumption Value Market Share by Type (2017-2028)
Figure 29. Global Attenuated Vaccine Average Price by Type (2017-2028) & (US$/Dose)
Figure 30. Global Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 31. Global Attenuated Vaccine Consumption Value Market Share by Application (2017-2028)
Figure 32. Global Attenuated Vaccine Average Price by Application (2017-2028) & (US$/Dose)
Figure 33. North America Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 34. North America Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 35. North America Attenuated Vaccine Sales Quantity Market Share by Country (2017-2028)
Figure 36. North America Attenuated Vaccine Consumption Value Market Share by Country (2017-2028)
Figure 37. United States Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 38. Canada Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Mexico Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Europe Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 41. Europe Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 42. Europe Attenuated Vaccine Sales Quantity Market Share by Country (2017-2028)
Figure 43. Europe Attenuated Vaccine Consumption Value Market Share by Country (2017-2028)
Figure 44. Germany Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 45. France Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. United Kingdom Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. Russia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Italy Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Asia-Pacific Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 50. Asia-Pacific Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 51. Asia-Pacific Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Attenuated Vaccine Consumption Value Market Share by Region (2017-2028)
Figure 53. China Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 54. Japan Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Korea Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. India Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. Southeast Asia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Australia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. South America Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 60. South America Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 61. South America Attenuated Vaccine Sales Quantity Market Share by Country (2017-2028)
Figure 62. South America Attenuated Vaccine Consumption Value Market Share by Country (2017-2028)
Figure 63. Brazil Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East & Africa Attenuated Vaccine Sales Quantity Market Share by Type (2017-2028)
Figure 66. Middle East & Africa Attenuated Vaccine Sales Quantity Market Share by Application (2017-2028)
Figure 67. Middle East & Africa Attenuated Vaccine Sales Quantity Market Share by Region (2017-2028)
Figure 68. Middle East & Africa Attenuated Vaccine Consumption Value Market Share by Region (2017-2028)
Figure 69. Turkey Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 70. Egypt Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Africa Attenuated Vaccine Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. Attenuated Vaccine Market Drivers
Figure 74. Attenuated Vaccine Market Restraints
Figure 75. Attenuated Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Attenuated Vaccine in 2021
Figure 78. Manufacturing Process Analysis of Attenuated Vaccine
Figure 79. Attenuated Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
